youtube_live
Q2 2027 earnings • released • EPS beat +20,18% • Revenue beat +16,41%
See resultschevron_right
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 530,00 ₹
arrow_upward
+1,19%(+29,80) 1D
6 նոյ, 15:30:01 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 502,00 ₹
High
2 544,80 ₹
Low
2 489,30 ₹
Mkt. cap
428,60 մլրդ
Avg. vol.
71,18 հզր
Volume
117,40 հզր
Dividend
2,25%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
37,38
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
67,68 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
Open
2 502,00 ₹
High
2 544,80 ₹
Low
2 489,30 ₹
Mkt. cap
428,60 մլրդ
Avg. vol.
71,18 հզր
Volume
117,40 հզր
Dividend
2,25%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
37,38
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
67,68 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Bergen Record
·
49 րոպե առաջ
Stagwell Inc. (STGW) Reports Equity Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
goSkagit
·
23 րոպե առաջ
Financial Markets Wall Street
Investing.com
·
31 րոպե առաջ
ZipRecruiter (NASDAQ:ZIP) cto Shimanovsky sells $140,877 in shares
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3,1 հզր
Founded13 նոյ, 1924 թ.
Headquarters-
SectorHealth Care
Industry-
Websiteindia-pharma.gsk.com